KOENIG SHELDON L. (Chief Operating Officer) reported 1 transaction at ESPERION THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/13/2026ACC: 0001628280-26-047999
Officer· Chief Operating Officer
Since Dec 2020
-4.16M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
4.16M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.12M
Price / share
—
Trade value
—
% of position
New position
7/13/2026
2.12M→0.00
Total
Net shares
−2.12M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/13/2026 | D · Disposition | −2.12M | — | — | New position | 2.12M | 0.00 |
| Total | −2.12M | $0.00 | ||||||
Derivative Transactions3
Stock Option (right to buy)
Direct
Converts to
Common Stock
642K shares
Shares
−642K
Strike price
2.05
Held after
0.00
Exercisable
—
7/13/2026
Stock Option (right to buy
Direct
Converts to
Common Stock
753K shares
Shares
−753K
Strike price
1.50
Held after
0.00
Exercisable
—
7/13/2026
Stock Option (right to buy)
Direct
Converts to
Common Stock
647.46K shares
Shares
−647.46K
Strike price
2.44
Held after
0.00
Exercisable
—
7/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock642K shares | 7/13/2026 | D · Disposition | −642K | 2.05 | — | 0.00 |
| Stock Option (right to buy Direct | Common Stock753K shares | 7/13/2026 | D · Disposition | −753K | 1.50 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock647.46K shares | 7/13/2026 | D · Disposition | −647.46K | 2.44 | — | 0.00 |